The effect of intravenous iron on fgf23 and iron profile

Phase 2

Recruiting

• Conditions: Iron deficiency anemia in hemodialysis patients.; Chronic kidney disease, stage 5; N18.5

• Registration Number: IRCT20190506043488N1
• Lead Sponsor: Zahedan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 45

Inclusion Criteria

All patients with hemodialysis who have completed their dialysis for at least 3 months.
All patients with hemodialysis aged 18 to 70 years.
All patients with hemodialysis have ferritin less than 200 and transferin saturation less than 20 %.

Exclusion Criteria

Dissatisfaction patients to enter the study
transfusion
Malignancy
Parathyroidectomy
Infection of any type ( catheter infection, UTI,....)
Recent consumption of corticosteroid
Active bleeding
Advanced heart disease
liver disease

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Fibroblast growth factor 23 level. Timepoint: Measurement of Fibroblast growth factor 23 level at the beginning of the study (before intervention) and 3 months after intervention. Method of measurement: Laboratory measurement.